Beyond our own pipeline, we partner with biotech companies, health systems, and distributors across four core service lines — each run under the same governance standard as our internal programs.
Our Wilmington and Cork sites take on third-party manufacturing for biologics and small molecules, from process development through commercial-scale production.
Audited to the same quarterly standard as our own batches, with full analytical testing and batch release.
We license out non-core compounds and license in promising early candidates, structured through the same Science & Technology Committee review.
Milestone-based royalty structuring with full data transparency on both sides.
Smaller biotechs engage our regulatory affairs team to navigate IND filings, trial design, and multi-market submissions.
Drawing on the in-house expertise that runs our own eleven-program pipeline.
For approved therapies entering new markets, our market access team handles pricing strategy, payer negotiation, and distribution partnerships.
Informed by the same outcomes-based pricing principle our board holds us to internally.
View More
Four steps from first conversation to signed agreement.
Reach our partnerships team via the contact page with a brief project outline.
Our technical team assesses scope, capacity, and regulatory fit within two weeks.
Larger engagements pass through the relevant board committee before terms are set.
Contracts finalized and a dedicated project lead assigned on our side.
Seven Pharmacist's contract manufacturing team scaled our process in under six months without a single deviation in batch records. Their QC team caught issues ours hadn't — that level of rigor is what we were paying for.Operations Director, Partner Biotech